Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.75 | N/A |
| PEG Ratio (TTM) | 0.36 | N/A |
| P/S Ratio (TTM) | 1.61 | N/A |
| P/B Ratio (TTM) | 1.92 | N/A |
| P/FCF Ratio (TTM) | 21.83 | N/A |
| Price to 5YR AVG Earnings Ratio | -482.38 | N/A |
| Price to 5YR AVG FCF Ratio | 25.27 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.95% | N/A |
| ROE (TTM) | 6.13% | N/A |
| Net Profit Margin (TTM) | 4.92% | N/A |
| ROIC 5YR AVG | 10.09% | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 206.57% | -187.93% | -111.70% |
| Revenue | 0.88% | 1.43% | 0.30% |
| Net Income | 208.47% | -189.16% | -113.01% |
| Cash Flow | 169.15% | 17.37% | 6.66% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.38 | N/A |
| Quick Ratio (TTM) | 1.26 | N/A |
| D/E Ratio (TTM) | 0.35 | N/A |
| Interest Coverage (TTM) | 8.76 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 1.94 | N/A |
| LTL to 5YR AVG FCF | 5.99 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.46% | N/A |